AT13148
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AT13148, covering 2018-07-20 to 2018-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of AT13148, a Novel AGC Kinase Inhibitor [Phase 1]